Nordisk Pharma ApS

CVR 42852287 · Private limited company (ApS) · Active · Low risk

Nordisk Pharma ApS is a Private limited company (ApS), founded on , based in Vallensbæk. The company is registered in the industry fremstilling af medicinske og dentale instrumenter samt udstyr hertil. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 1.2m and a net result of DKK 207k. CEO: Sanad Emad Hussein Al Bidany.

Bankruptcy risk for Nordisk Pharma ApS

0.1%
probability of bankruptcy within 12 months
Low risk

0.1 × the average (1.41%) · higher risk than 38% of active Danish companies

Lowest riskHighest risk

Increases the risk

Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Published annual reports3–5 · bankruptcy rate 11.7%1.3×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Loss for the yearNo · bankruptcy rate 5.3%0.60×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
42852287
Status
Active
Company type
Private limited company (ApS)
Founded
(4 years)
Address
Stenkløvervænget 21
2625 Vallensbæk
Municipality
Vallensbæk
Industry
Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (325000)
Bankruptcies in the industry: Fremstilling af medicinske og dentale instrumenter samt udstyr hertil
Share capital
DKK 340k
Auditor
ReviTotalStatsautoriseret Revisionsfirma
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 4
Missing annual reportNo
Negative equityNo
Equity ratio84.2%
Current ratio631%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK 365kDKK 553kDKK 332k
Net profitDKK 207kDKK 426kDKK 263k
EquityDKK 1.2mDKK 1.0mDKK 584k
Total assetsDKK 1.4mDKK 1.3mDKK 747k
CashDKK 1.2mDKK 1.1m–
Short-term debtDKK 229kDKK 298k–
Tax owed–DKK 122k–
Avg. employees00–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · ReviTotalStatsautoriseret Revisionsfirma.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025161
1 Jan 2024 – 31 Dec 2024173
1 Jan 2023 – 31 Dec 2023161
17 Nov 2021 – 31 Dec 2022165

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOSanad Emad Hussein Al BidanyCurrent
Owner (100%)Nordisk Pharma Holding ApSCurrent
FounderNordisk Pharma Holding ApSCurrent

The CEOs' other companies

Sanad Emad Hussein Al Bidany – 2 other companies

Address history (0 moves)

Stenkløvervænget 21, 2625 Vallensbæk

Other companies at the same address

Similar companies in Vallensbæk

Questions and answers about Nordisk Pharma ApS

Has Nordisk Pharma ApS gone bankrupt?

No, Nordisk Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Nordisk Pharma ApS?

Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.

Who is the CEO of Nordisk Pharma ApS?

Sanad Emad Hussein Al Bidany is the CEO of Nordisk Pharma ApS.

Who is the auditor of Nordisk Pharma ApS?

Nordisk Pharma ApS most recently used ReviTotalStatsautoriseret Revisionsfirma.

When was Nordisk Pharma ApS founded?

Nordisk Pharma ApS was founded on 17 November 2021.

What is the equity of Nordisk Pharma ApS?

Equity was DKK 1.2m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.